OtherArticle
N-Glucuronidation of the PDGF Receptor Tyrosine Kinase Inhibitor 6,7-(Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)-(3-fluoro-phenyl)-amine by Human UDP-Glucuronosyltransferases
Zhengyin Yan, Gary W Caldwell, Diane Gauthier, Gregory C Leo, Jay Mei, Ho Y Chih, Wiilliam J Jones, John A Masucci, Robert W Tuman, Robert J Galemmo and Dana L Johnson
Drug Metabolism and Disposition February 2, 2006, DOI: https://doi.org/10.1124/dmd.106.009274
Zhengyin Yan
Gary W Caldwell
Diane Gauthier
Gregory C Leo
Jay Mei
Ho Y Chih
Wiilliam J Jones
John A Masucci
Robert W Tuman
Robert J Galemmo
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherArticle
N-Glucuronidation of the PDGF Receptor Tyrosine Kinase Inhibitor 6,7-(Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)-(3-fluoro-phenyl)-amine by Human UDP-Glucuronosyltransferases
Zhengyin Yan, Gary W Caldwell, Diane Gauthier, Gregory C Leo, Jay Mei, Ho Y Chih, Wiilliam J Jones, John A Masucci, Robert W Tuman, Robert J Galemmo and Dana L Johnson
Drug Metabolism and Disposition February 2, 2006, DOI: https://doi.org/10.1124/dmd.106.009274
OtherArticle
N-Glucuronidation of the PDGF Receptor Tyrosine Kinase Inhibitor 6,7-(Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)-(3-fluoro-phenyl)-amine by Human UDP-Glucuronosyltransferases
Zhengyin Yan, Gary W Caldwell, Diane Gauthier, Gregory C Leo, Jay Mei, Ho Y Chih, Wiilliam J Jones, John A Masucci, Robert W Tuman, Robert J Galemmo and Dana L Johnson
Drug Metabolism and Disposition February 2, 2006, DOI: https://doi.org/10.1124/dmd.106.009274
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement